Dr. Brar is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2825 Livernois Rd
Troy, MI 48083Phone+1 313-916-2600
Education & Training
- Boston University Medical CenterFellowship, Infectious Disease, 1994 - 1997
- UMass Chan Medical SchoolResidency, Internal Medicine, 1991 - 1993
- SUNY Downstate Health Sciences UniversityInternship, Internal Medicine, 1990 - 1991
- Christian Medical College LudhianaClass of 1987
Certifications & Licensure
- MI State Medical License 1998 - 2026
- MA State Medical License 1992 - 2003
- American Board of Internal Medicine Infectious Disease
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Clinical Trials
- Post-Exposure Prophylaxis in Health Care Workers Start of enrollment: 2011 Feb 01
Publications & Presentations
PubMed
- 425 citationsClinical Characteristics and Morbidity Associated With Coronavirus Disease 2019 in a Series of Patients in Metropolitan Detroit.Geehan Suleyman, Raef Fadel, Kelly M. Malette, Charles Hammond, Hafsa Abdulla
JAMA Network Open. 2020-06-01 - 140 citationsSpectrum of Bacille Calmette-Guérin (BCG) Infection after Intravesical BCG ImmunotherapyOmar Gonzalez, Daniel M. Musher, Indira Brar, Seth B. Furgeson, Maha Boktour
Clinical Infectious Diseases. 2003-01-15 - 342 citationsTreatment with hydroxychloroquine, azithromycin, and combination in patients hospitalized with COVID-19.Samia Arshad, Paul E. Kilgore, Zohra S Chaudhry, Gordon Jacobsen, Dee Dee Wang
International Journal of Infectious Diseases. 2020-08-01
Press Mentions
- Global Health Research Collaborative Panel Discussions Open to All Beginning July 22July 11th, 2022
- OTC Meds, Supplements, and Other Drugs May Interact with HIV AntiretroviralsMay 23rd, 2022
- Despite FDA Delay, Convalescent Plasma Trials Continue in MichiganAugust 20th, 2020
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: